from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
Are Telix shares a buy after flying 40% higher in March?
-
Why this ASX REIT is quietly pushing back toward its takeover price
-
Up 54% in 2026, are Woodside shares still a good buy today?
-
Down 50% in 2026, Zip shares are ‘one of the most compelling value opportunities on the ASX’